[1]
S. H. Hutajulu, “Clinicopathological Factors and Interleukin-6 Levels Associated With Low Relative Dose Intensity in Women With Breast Cancer Receiving First-Line Chemotherapy”, World J Oncol, vol. 15, no. 6, pp. 942–949, Dec. 2024, doi: 10.14740/wjon1954.